These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3802381)

  • 1. Limited efficacy of a four-day course of high-dose cytosine arabinoside in the treatment of poor-risk patients with acute nonlymphocytic leukemia.
    Preisler HD; Raza A; Larson R; Browman G; Goldberg J; Grunwald H; Vogler R; Bennett J; Gottlieb A; D'Arrigo P
    Cancer Chemother Pharmacol; 1986; 18(3):257-60. PubMed ID: 3802381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose cytosine arabinoside as the initial treatment of poor-risk patients with acute nonlymphocytic leukemia: a Leukemia Intergroup Study.
    Preisler HD; Raza A; Barcos M; Azarnia N; Larson R; Walker I; Browman M; Grunwald H; D'Arrigo P; Doeblin T
    J Clin Oncol; 1987 Jan; 5(1):75-82. PubMed ID: 3806162
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose cytosine arabinoside treatment for acute nonlymphocytic leukemia in elderly patients.
    Tilly H; Castaigne S; Bordessoule D; Sigaux F; Daniel MT; Monconduit M; Degos L
    Cancer; 1985 Apr; 55(8):1633-6. PubMed ID: 3978558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of response of acute nonlymphocytic leukaemia to therapy with 'high dose' cytosine arabinoside.
    Preisler HD; Epstein J; Barcos M; Priore R; Raza A; Browman GP; Vogler R; Winton E; Grunwald H; Rai K
    Br J Haematol; 1984 Sep; 58(1):19-32. PubMed ID: 6466567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of intensive postremission chemotherapy for adults with acute nonlymphocytic leukemia using high-dose cytosine arabinoside with L-asparaginase and amsacrine with etoposide.
    Tallman MS; Appelbaum FR; Amos D; Goldberg RS; Livingston RB; Mortimer J; Weiden PL; Thomas ED
    J Clin Oncol; 1987 Jun; 5(6):918-26. PubMed ID: 3585446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An attempt at synchronization of marrow cells in acute leukemia: relationship to therapeutic response.
    Kremer WB; Vogler WR; Chan YK
    Cancer; 1976 Jan; 37(1):390-403. PubMed ID: 1082365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-dose cytosine arabinoside, daunomycin and 6-thioguanine in relapsed or refractory acute nonlymphocytic leukemia.
    Garewal H; Durie BG; Greenberg B
    Oncology; 1987; 44(6):333-5. PubMed ID: 3684173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia.
    Chan HY; Meyers FJ; Lewis JP
    Cancer Chemother Pharmacol; 1987; 20(3):265-6. PubMed ID: 3677301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abrogation of the prognostic significance of low leukemic cell retention of cytosine arabinoside triphosphate by intensification of therapy and by alteration in the dose and schedule of administration of cytosine arabinoside.
    Preisler HD; Rustum YM; Azarnia N; Priore R
    Cancer Chemother Pharmacol; 1987; 19(1):69-74. PubMed ID: 3815728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemotherapy for adult acute nonlymphocytic leukemia with daunorubicin and cytosine arabinoside.
    Cassileth PA; Katz ME
    Cancer Treat Rep; 1977 Nov; 61(8):1441-5. PubMed ID: 922749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-dose cytosine arabinoside in the consolidation therapy of acute nonlymphocytic leukemia in remission.
    Takaku F; Urabe A; Mizoguchi H; Hoshino S; Toyama K; Tanaka K; Nomura T; Dan K; Fujioka S; Saito T
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):55-7. PubMed ID: 3589698
    [No Abstract]   [Full Text] [Related]  

  • 12. Remission induction in acute nonlymphocytic leukemia: comparison of a seven-day and ten-day infusion of cytosine arabinoside in combination with adriamycin.
    Preisler H; Bjornsson S; Henderson ES; Hryniuk W; Higby D; Freeman A; Naeher C
    Med Pediatr Oncol; 1979; 7(3):269-75. PubMed ID: 542191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose cytosine arabinoside therapy with and without anthracycline antibiotics for remission reinduction of acute nonlymphoblastic leukemia.
    Herzig RH; Lazarus HM; Wolff SN; Phillips GL; Herzig GP
    J Clin Oncol; 1985 Jul; 3(7):992-7. PubMed ID: 3894588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of refractory leukemia with high-dose cytosine arabinoside.
    Klener P; Háber J
    Neoplasma; 1985; 32(1):113-7. PubMed ID: 3856754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-dose cytosine arabinoside and daunorubicin as consolidation therapy for acute nonlymphocytic leukemia in first remission: an update.
    Wolff SN; Herzig RH; Phillips GL; Lazarus HM; Greer JP; Stein RS; Ray WA; Herzig GP
    Semin Oncol; 1987 Jun; 14(2 Suppl 1):12-7. PubMed ID: 3589687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Value of high-dose cytosine-arabinoside in the treatment of resistant acute leukemia].
    Witz F; Olive D; Lederlin P; Bordigoni P; Troussard X; Grosbois B; Schaison G; Cornu G
    Presse Med; 1987 Feb; 16(4):159-62. PubMed ID: 2950446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-dose cytosine arabinoside and m-AMSA is effective therapy in relapsed acute nonlymphocytic leukemia.
    Hines JD; Oken MM; Mazza JJ; Keller AM; Streeter RR; Glick JH
    J Clin Oncol; 1984 Jun; 2(6):545-9. PubMed ID: 6233399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I-II clinical and pharmacologic studies of high-dose cytosine arabinoside in refractory leukemia.
    Kantarjian HM; Estey EH; Plunkett W; Keating MJ; Walters RS; Iacoboni S; McCredie KB; Freireich EJ
    Am J Med; 1986 Sep; 81(3):387-94. PubMed ID: 3463209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
    Zeremski V; Savić A
    Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intermediate-dose cytosine arabinoside and amsacrine. An effective regimen with low toxicity in refractory acute nonlymphocytic leukemia.
    Dekker AW; Nieuwenhuis HK; Verdonck LF
    Cancer; 1990 May; 65(9):1891-4. PubMed ID: 2372760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.